• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man.

作者信息

Bäärnhielm C, Dahlbäck H, Skånberg I

出版信息

Acta Pharmacol Toxicol (Copenh). 1986 Aug;59(2):113-22. doi: 10.1111/j.1600-0773.1986.tb00142.x.

DOI:10.1111/j.1600-0773.1986.tb00142.x
PMID:3776550
Abstract

The elimination of felodipine in liver microsomes from dog and man were characterized by Km and Vmax. The results were compared with previous data reported for rat. In all species studied, felodipine was primarily metabolized to its corresponding pyridine analogue. The elimination rate order was rat greater than dog greater than man. The same species difference was observed in vivo for the oral plasma clearance which was; rat 26 1/hr/kg, dog 7.5 1/hr/kg and man 4.3 1/hr/kg. The intrinsic hepatic clearance of felodipine was predicted in vitro from Vmax over Km. The in vitro values were not significantly different from those observed in vivo. Felodipine is a high-clearance drug and the in vivo extraction ratios were about the same in all species: rat 0.80, dog 0.83 and man 0.84. The extraction ratios predicted from the in vitro studies, rat 0.91, dog 0.70 and man 0.80, agreed well with those observed in vivo.

摘要

相似文献

1
In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man.
Acta Pharmacol Toxicol (Copenh). 1986 Aug;59(2):113-22. doi: 10.1111/j.1600-0773.1986.tb00142.x.
2
Biotransformation of felodipine in liver microsomes from rat, dog, and man.非洛地平在大鼠、犬和人的肝微粒体中的生物转化。
Drug Metab Dispos. 1986 Sep-Oct;14(5):613-8.
3
Stereoselective metabolism of felodipine in liver microsomes from rat, dog, and human.非洛地平在大鼠、犬和人肝脏微粒体中的立体选择性代谢。
Drug Metab Dispos. 1991 Sep-Oct;19(5):889-94.
4
Cytochrome P-450-dependent oxidation of felodipine--a 1,4-dihydropyridine--to the corresponding pyridine.
Xenobiotica. 1984 Sep;14(9):719-26. doi: 10.3109/00498258409151470.
5
Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.茚地那韦(一种有效的人类免疫缺陷病毒蛋白酶抑制剂)在药代动力学和代谢方面的种属差异。
Drug Metab Dispos. 1996 Oct;24(10):1111-20.
6
Correlation of the intrinsic clearance of donepezil (Aricept) between in vivo and in vitro studies in rat, dog and human.多奈哌齐(安理申)在大鼠、犬和人体体内与体外研究中内在清除率的相关性。
Xenobiotica. 1999 Nov;29(11):1059-72. doi: 10.1080/004982599237958.
7
In vitro to in vivo extrapolation and physiologically based modeling of cytochrome P450 mediated metabolism in beagle dog gut wall and liver.在体到体外表观和基于生理的比格犬肠道壁和肝脏细胞色素 P450 介导代谢的建模。
Mol Pharm. 2013 Apr 1;10(4):1388-99. doi: 10.1021/mp300692k. Epub 2013 Mar 13.
8
Metabolism of ezlopitant, a nonpeptidic substance P receptor antagonist, in liver microsomes: enzyme kinetics, cytochrome P450 isoform identity, and in vitro-in vivo correlation.非肽类P物质受体拮抗剂依洛匹坦在肝微粒体中的代谢:酶动力学、细胞色素P450同工酶鉴定及体外-体内相关性
Drug Metab Dispos. 2000 Sep;28(9):1069-76.
9
Utility of hepatocytes to model species differences in the metabolism of loxtidine and to predict pharmacokinetic parameters in rat, dog and man.肝细胞用于模拟洛昔替丁代谢中的物种差异以及预测大鼠、犬和人体药代动力学参数的效用。
Xenobiotica. 1999 Mar;29(3):253-68. doi: 10.1080/004982599238650.
10
In vivo and in vitro kinetics of mofarotene in mouse, rat, dog and man.莫法罗汀在小鼠、大鼠、犬和人体中的体内及体外动力学
Eur J Drug Metab Pharmacokinet. 1995 Jan-Mar;20(1):49-53. doi: 10.1007/BF03192288.

引用本文的文献

1
Liver microsomal protein content and activity in patients with hepatocellular carcinoma and cirrhosis: implications for the prediction of individual hepatic clearance.肝细胞癌和肝硬化患者肝脏微粒体蛋白含量及活性:对个体肝脏清除率预测的意义
J Gastrointest Oncol. 2025 Feb 28;16(1):146-158. doi: 10.21037/jgo-2024-963. Epub 2025 Feb 24.
2
Identification and characterization of a first-generation inhibitor of claudin-1 in colon cancer progression and metastasis.鉴定和表征第一代 Claudin-1 抑制剂在结肠癌进展和转移中的作用。
Biomed Pharmacother. 2023 Mar;159:114255. doi: 10.1016/j.biopha.2023.114255. Epub 2023 Jan 23.
3
Assessment of Tissue Distribution and Metabolism of MP1, a Novel Pyrrolomycin, in Mice Using a Validated LC-MS/MS Method.
使用经过验证的液相色谱-串联质谱法评估新型吡咯霉素MP1在小鼠体内的组织分布和代谢
Molecules. 2020 Dec 13;25(24):5898. doi: 10.3390/molecules25245898.
4
Comparison of in vivo derived and scaled in vitro metabolic rate constants for several volatile organic compounds (VOCs).比较几种挥发性有机化合物(VOCs)的体内衍生和体外比例代谢率常数。
Toxicol In Vitro. 2020 Dec;69:105002. doi: 10.1016/j.tiv.2020.105002. Epub 2020 Sep 15.
5
Content and activity of human liver microsomal protein and prediction of individual hepatic clearance in vivo.人肝微粒体蛋白的含量与活性及体内个体肝清除率的预测
Sci Rep. 2015 Dec 4;5:17671. doi: 10.1038/srep17671.
6
Benzimidazole analogs as potent hypoxia inducible factor inhibitors: synthesis, biological evaluation, and profiling drug-like properties.苯并咪唑类似物作为有效的缺氧诱导因子抑制剂:合成、生物评价和药物特性分析。
Anticancer Res. 2014 Aug;34(8):3891-904.
7
Quantitative ADME proteomics - CYP and UGT enzymes in the Beagle dog liver and intestine.定量药物代谢动力学蛋白质组学——比格犬肝脏和肠道中的细胞色素P450酶和尿苷二磷酸葡萄糖醛酸转移酶
Pharm Res. 2015 Jan;32(1):74-90. doi: 10.1007/s11095-014-1446-8. Epub 2014 Jul 18.
8
Mass spectrometry-based quantification of CYP enzymes to establish in vitro/in vivo scaling factors for intestinal and hepatic metabolism in beagle dog.基于质谱的 CYP 酶定量分析,建立比格犬肠道和肝脏代谢的体外/体内转化因子。
Pharm Res. 2012 Jul;29(7):1832-42. doi: 10.1007/s11095-012-0707-7. Epub 2012 Feb 22.
9
Determinants of cytochrome P450 2C8 substrate binding: structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid.细胞色素P450 2C8底物结合的决定因素:与孟鲁司特、曲格列酮、非洛地平和9-顺式视黄酸复合物的结构
J Biol Chem. 2008 Jun 20;283(25):17227-37. doi: 10.1074/jbc.M802180200. Epub 2008 Apr 15.
10
Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT1A1, 1A3 and 1A8.DRF-4367(一种新型COX-2抑制剂)的羟基代谢产物DRF-6574在人肝匀浆、肠微粒体及重组人尿苷二磷酸葡萄糖醛酸基转移酶(UGT)中的葡萄糖醛酸化作用:UGT1A1、1A3和1A8的作用
Eur J Drug Metab Pharmacokinet. 2006 Oct-Dec;31(4):299-309. doi: 10.1007/BF03190471.